Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymorphone ER in pediatric chronic or postsurgical pain
NCT04681027Phase 3Suspended
- Sponsor
- Endo International plc
- Start
- Mar 2013
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxymorphone in chronic pain, Persistent postsurgical pain (PPSP), sponsored by Endo International plc. Started Mar 2013; status: suspended.
02
Drugs
oxymorphone
03
Conditions
chronic painPersistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT04681027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04681027.